gastroesophageal cancer | sciencenewsnet.in

Breaking News

CHOP Researchers Identify Causal Genetic Variant Linked to Common Childhood Obesity

Study: Hillocks challenge our understanding of lung biology

Register for Food and Nutrition Institute’s Fourth Annual Conference on Science, Regulation

Mayo Clinic Laboratories and Progentec Diagnostics launch lupus advanced biomarker testing services

May is Mental Health Awareness Month

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

Plant-LncPipe: a new tool for plant long non-coding RNA (lncRNA) identification

New findings point to an Earth-like environment on ancient Mars

At the Climate READi workshop: Resilient power systems in the context of climate change

New Podcast Series Launched to Confront Burnout and Moral Injury in Healthcare

01 May, 2024

Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response

March 20, 2024 sarah JonasResearch Results

The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.

Circulating Tumor DNA Levels Predict Treatment Outcomes for Patients with Gastroesophageal Cancer Treated with a Novel Immunotherapy Combination

March 19, 2024 sarah JonasResearch Results

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Baylor Scott & White Shares Insights At ACG Annual Scientific Meeting 2023

October 23, 2023 sarah JonasResearch Alert

The 2023 American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course will convene in Vancouver, Canada, Oct. 20-25. The ACG is a recognized leader in educating GI professionals and the public about digestive disorders. The ACG’s mission is…

Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer

May 16, 2022 sarah JonasResearch Results

Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, immunotherapy has been shown to prolong survival when patients’ tumors exhibit a high expression of an immune-related protein called PD-L1.

Roswell Park Experts Highlight Opportunities to Improve Outcomes for People with Gastroesophageal Cancer

July 2, 2021 sarah JonasResearch Results

Two Roswell Park Comprehensive Cancer Center experts were invited to present new insights on treatment of gastroesophageal cancers during the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021. In their talks, both presented July 1, the Roswell Park physician-researchers highlighted easily adoptable methods that may help other clinicians to provide care supporting improved patient outcomes.